Clinical Trial Update: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin and gemcitabine with or without vandetanib as first-line therapy for locally advanced or metastatic urinary tract cancers; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter
• Ureter Cancer
• Urethral Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Vandetanib (vandetanib)

Snippet

Sponsor: Cardiff University | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED